GERN
Geron Corp
Price:  
1.34 
USD
Volume:  
3,606,581.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-240.0%
Upside

As of 2025-12-31, the EV/EBITDA ratio of Geron Corp (GERN) is -16.40. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 1,025.88 mil USD. GERN's TTM EBITDA according to its financial statements is -62.54 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.6x - 15.3x 14.0x
Forward P/E multiples 15.9x - 21.9x 18.9x
Fair Price (1.82) - (1.77) (1.88)
Upside -236.2% - -231.8% -240.0%
1.34 USD
Stock Price
(1.88) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-12-26 -16.71
2025-12-24 -17.02
2025-12-23 -16.30
2025-12-22 -16.51
2025-12-19 -16.30
2025-12-18 -16.40
2025-12-17 -17.02
2025-12-16 -16.40
2025-12-15 -16.30
2025-12-12 -16.61
2025-12-11 -16.91
2025-12-10 -15.79
2025-12-09 -15.28
2025-12-08 -15.69
2025-12-05 -16.10
2025-12-04 -15.69
2025-12-03 -15.69
2025-12-02 -15.28
2025-12-01 -14.87
2025-11-28 -14.77
2025-11-26 -14.87
2025-11-25 -14.57
2025-11-24 -14.57
2025-11-21 -14.16
2025-11-20 -13.95
2025-11-19 -13.75
2025-11-18 -14.06
2025-11-17 -14.26
2025-11-14 -14.16
2025-11-13 -14.46
2025-11-12 -15.38
2025-11-11 -15.49
2025-11-10 -14.57
2025-11-07 -13.65
2025-11-06 -13.75
2025-11-05 -13.85
2025-11-04 -14.46
2025-11-03 -14.97
2025-10-31 -15.59
2025-10-30 -15.38
2025-10-29 -15.28
2025-10-28 -15.79
2025-10-27 -15.79
2025-10-24 -15.38
2025-10-23 -15.18
2025-10-22 -15.38
2025-10-21 -15.69
2025-10-20 -15.69
2025-10-17 -14.97
2025-10-16 -15.28